New injection method tested for fever-related infection risk
NCT ID NCT06918587
First seen Apr 24, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This study tested two different ways to give a single dose of a drug used to prevent infections in people with low white blood cells (febrile neutropenia). 180 healthy adults received the drug either through a pre-filled syringe or an on-body injector. Researchers measured how much drug got into the blood, checked for side effects, and looked for immune reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEBRILE NEUTROPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Al-Essra Hospital
Amman, Jordan, 11941, Jordan
Conditions
Explore the condition pages connected to this study.